1066 — Shandong Weigao Medical Polymer Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapContrarian

Market Cap
HK$23.31bn
Enterprise Value
HK$21.56bn
Revenue
CNY13.23bn

Annual income statement for Shandong Weigao Medical Polymer Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	R2019 December 31st	R2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	PRESS	PRESS
Standards:	HKAS	HKAS	HKAS	—	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	10,384	11,622	13,209	13,747	13,229
Cost of Revenue
Gross Profit	6,514	6,500	7,353	7,306	6,643
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,815	8,887	10,260	10,245	10,664
Operating Profit	2,569	2,735	2,949	3,502	2,565
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	2,252	2,565	2,878	3,386	2,369
Provision for Income Taxes
Net Income After Taxes	1,925	2,207	2,458	2,950	2,062
Minority Interest
Net Income Before Extraordinary Items
Net Income	1,850	2,087	2,276	2,764	2,002
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	1,850	2,087	2,275	2,763	2,002
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.42	0.471	0.549	0.651	0.447
Dividends per Share